113722-25-1 Usage
Uses
Used in Pharmaceutical Industry:
2H-1-Benzopyran-8-aMine, 3,4-dihydrois used as a key building block for the synthesis of pharmaceuticals. Its unique structure and properties make it a valuable component in the development of new drugs and medicinal compounds.
Used in Organic Synthesis:
2H-1-Benzopyran-8-aMine, 3,4-dihydrois used as a starting material in the synthesis of various organic compounds. Its versatility allows for the creation of a wide range of chemical products, making it an important tool in organic chemistry.
Used in Research and Development:
2H-1-Benzopyran-8-aMine, 3,4-dihydrois used as a research chemical in the study of heterocyclic chemistry and drug development. Its presence in natural products and pharmaceuticals makes it an interesting subject for scientific investigation and potential applications in medicine and other fields.
Check Digit Verification of cas no
The CAS Registry Mumber 113722-25-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,7,2 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 113722-25:
(8*1)+(7*1)+(6*3)+(5*7)+(4*2)+(3*2)+(2*2)+(1*5)=91
91 % 10 = 1
So 113722-25-1 is a valid CAS Registry Number.
113722-25-1Relevant articles and documents
SYNTHESIS OF AMINO-SUBSTITUTED 2-METHYLCOUMARINS, CHROMANS, AND BENZOXEPANES AND THEIR N-(ALKYLAMINOACYL) DERIVATIVES
Daukshas, V. K.,Pyatrauskas, O. Yu.,Purvanyatskas, G. N.
, p. 266 - 270 (1987)
The isomeric compositions of the products of nitration of 2-methylcoumaran and chroman with acetyl nitrate were determined.More convenient methods for the synhtesis of 7-amino-2-methylcoumaran and 8-aminochroman were developed, and 9-amino-1-benzoxepane was obtained for the first time.Alkylaminoacylaminosubstituted 2-methylcoumarans, chromans, and 1-benzoxepanes were synthesized.A method for the synthesis of 2-bromocaproyl chloride from caproic acid was developed.
7-(METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES
-
, (2020/07/07)
The present invention provides a compound of Formula (I) wherein R is (II) or (III); or a pharmaceutically acceptable salt thereof, useful for treating psoriasis or systemic lupus erythematosus.